|Day Low/High||13.78 / 14.40|
|52 Wk Low/High||5.30 / 97.92|
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz's addition should pacify a persistent critique of the company.
* The consensus is growing more consensus! * The notion of risk has left the Exchange's building * The last hour of trading uncharacteristically weak Today's session was another one supported by good overall breadth (2,154/786 on the NYSE). Howeve...
* Nelson Peltz's imprimatur has value * But, from my perch, not $1 billion of value! "Buy Aurora Cannabis . Buy it because Nelson Peltz is now an advisor to the company with options to buy 20 million shares at a minimum. Buy it because Nelson's con...
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
The plan is for Peltz to help the firm in maximizing potential markets to target.
Themes like cannabis tend to persist longer than many think they will.
The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.
Aurora's addition of a big name activist is accelerating share growth.
In its first report on cannabis companies, Melius says prices are high.
I tend to focus more on individual stocks I'm holding rather than try to predict what the indices will do next.
The best move here is to stay focused on stock picking but manage positions tightly.
Right now they are speculative growth stocks through and through.
The company's first move into the cannabis space is in a joint venture with medical marijuana research company Emerald Farms.
I see two factors coming into play as the company reports earnings.
Without Apple doing so well Monday the indices would look much different.
Let's check out the charts of four big names in the space.
CBD could make coffee an around the clock craze.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Shares of Tilray, Canopy Growth and Aurora Cannabis are down sharply on Wednesday.
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Companies are adjusting their supply lines, but both the U.S. and Chinese administrations are feeling the heat.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.